Optimized turmeric extracts have potent anti-amyloidogenic effects

Current Alzheimer Research

Volumn 6, Issue 6, 2009, Pages 564-571

  Douglas Shytle, R ^a,c   Bickford, Paula C ^a,b,c   Rezai Zadeh, Kavon ^a   Hou, L ^a   Zeng, Jin ^a   Tan, Jun ^a,c   Sanberg, Paul R ^a,c   Sanberg, Cyndy D ^c   Roschek Jr , Bill ^d   Fink, Ryan C ^e   Alberte, Randall S ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Natura Therapeutics Inc   (United States)

^d HerbalScience Group LLC   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid aggregation; Amyloid secretion; Curcuminoids; DART TOF MS; Turmeric extracts

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CURCUMA LONGA EXTRACT; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; HSS 838; HSS 848; HSS 888; TETRAHYDROCURCUMIN; THIOFLAVINE; TURMERONE; UNCLASSIFIED DRUG; ZINGIBERENE; AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; PLANT EXTRACT; TURMERIC EXTRACT;

ARTICLE; BIOCHEMICAL COMPOSITION; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA LONGA; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NERVE CELL; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECRETION; TIME OF FLIGHT MASS SPECTROMETRY; CELL LINE; CULTURE MEDIUM; MASS SPECTROMETRY; METABOLISM; PHYTOTHERAPY;

AMYLOID BETA-PROTEIN; ANTI-INFLAMMATORY AGENTS; CELL LINE; CULTURE MEDIA, CONDITIONED; CURCUMA; CURCUMIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MASS SPECTROMETRY; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 73949140815     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509790147115     Document Type: Article

References (54)

1. Selkoe DJ. Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53: 438-447 (1994).
2. Golde TE, Dickson D, Hutton M. Filling the gaps in the Aβ hypothesis of Alzheimer's disease. Curr Alzheimer Res 3: 421-430 (2006).
3. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 71: 621S-629S (2000).
4. Cole GM, Morihara T, Lim GP, Yang F, Begum A, Frautschy SA. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Ann NY Acad Sci 1035: 68-84 (2004).
5. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609-7616 (1999).
6. El Khoury J, Hickman SE, Thomas CA, Loike JD, Silverstein SC. Microglia, scavenger receptors, and the pathogenesis of alzheimer's disease. neurobiol. Aging 19: S81-S84 (1998).
7. McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci 23: 2212-2217 (2003).
8. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24: 516-524 (2006).
9. Xiong K, Cai H, Luo X-G, Struble RG, Clough RW, Yan X-X. Mitochondrial respiratory inhibition and oxidative stress elevate??-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp Brain Res 181: 435-446 (2007).
10. Chauhan V, Chauhan A. Oxidative stress in Alzheimer's disease. Pathophysiology 13: 195-208 (2006).
11. LaFerla FM, Green KN, Oddo S. Intracellular amyloid in Alzheimer's disease. Nat Rev Neurosci 8: 449-509 (2007).
12. Pangalos MN, Schechter LE, Hurko O. Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 6: 521-532 (2007).
13. Melnikova I. Therapies for Alzheimer's disease. Nat Rev Drug Discov 6: 341-342 (2007).
14. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109 (Suppl 1): 69-75 (2001).
15. Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med 2: 465-473 (2005).
16. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25: 8807-8814 (2005).
17. Ray S, Chattopadhyay N, Mitra A, Siddiqi M, Chatterjee A. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and Ecadherin. J Environ Pathol Toxicol Oncol 22: 49-58 (2003).
18. Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol 595: 197-212 (2007).
19. Bhandarkar SS, Arbiser JL. Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595: 185-195 (2007).
20. Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R. Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 595: 173-184 (2007).
21. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595: 105-125 (2007).
22. Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 171: 6072-6079 (2003).
23. Jung KK, Lee HS, Cho JY, Shin WC, Rhee MH, Kim TG, et al. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci 79: 2022-2031 (2006).
24. Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75: 742-750 (2004).
25. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901 (2005).
26. Shukla PK, Khanna VK, Khan MY, Srimal RC. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 22: 653-658 (2003).
27. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377 (2001).
28. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993-1005 (2001).
29. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, et al. Role of pro-oxidants and antioxidants in the antiinflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43: 568-580 (2007).
30. Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50: 2191-2193 (2005).
31. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102: 1095-1104 (2007).
32. Jain S, Shrivastava S, Nayak S, Sumbhate S. PHCOG MAG: Plant Review. Recent trends in Curcuma longa Linn. Pharmacog Revs 1: 119-128 (2007).
33. Cody RB, Laramee JA, Durst HD. Versatile new ion source for the analysis of materials in open air under ambient conditions. Anal Chem 77: 2297-2302 (2005).
34. Roschek Jr. B, Fink RC, McMichael MD, Li D, Alberte RS. Elderberry flavonoids bind to and prevent H1N1 Infection in vitro. Phytochem. doi: 10.1016/j.phytochem.2009.06.003 (2009)
35. Gow RT, Li D, Sypert G, Alberte RS. Extracts and methods comprising curcuma species. Patent WO/2007/109210 (2007).
36. Stein S, Mirokhin Y, Tchekhovskoi D, Mallard G, Mikaia A, Zaikin V, et al. The NIST mass spectral search program for the NIST/EPA/NIH Mass Spectral Library - Version 2.0d Gaithersburg MD, National Institute of Standards and Technology (2005).
37. Hall C. Dictionary of Natural Products on DVD. USA: CRC Press (2008).
38. Moore SA, Huckerby TN, Gibson GL, Fullwood NJ, Turnbull S, Tabner BJ, et al. Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity. Biochemistry 43: 819-826 (2004).
39. LeVine H, 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2: 404-410 (1993).
40. Tan J, Town T, Crawford F, Mori T, DelleDonne A, Crescentini R, Obregon D, Flavell RA, Mullan MJ. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat Neurosci 5: 1288-1293 (2002).
41. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280: 37377-37382 (2005).
42. Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, et al. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate- induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 281: 16419-16427 (2006).
43. Delaney IV WE, Yang H, Miller MD, Gibbs CS, Xiong S. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro. Antimicrob. Agents Chemother 48: 3702-3710 (2004).
44. Fairbanks CA, Wilcox GL. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharm Exp Ther 288: 1107-1116 (1999).
45. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol 11: 13-19 (2008).
46. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28: 110-113 (2008).
47. Irie Y. Effects of eugenol on the central nervous system: its possible application to treatment of alzheimer's disease, depression, and parkinson's disease. Curr Bioact Compd 2: 57-66 (2006).
48. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, et al. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res 84: 418-426 (2006).
49. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci 9 (Suppl 2): S6 (2008).
50. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-356 (1998).
51. Lee HS. Antiplatelet property of Curcuma longa L. rhizomederived ar-turmerone. Bioresour Technol 97: 1372-1376 (2006).
52. Lee SK, Hong CH, Huh SK, Kim SS, Oh OJ, Min HY, et al. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J Environ Pathol Toxicol Oncol 21: 141-148 (2002).
53. Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28: 937-939 (2005).
54. Li G, Xu ML, Lee CS, Woo MH, Chang HW, Son JK. Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch Pharmacal Res 27: 829-833 (2004).